• 1
    Turner RT, Riggs BL, Spelsberg TC 1994 Skeletal effects of estrogen. Endocr Rev 16: 275300.
  • 2
    Harris SA, Tau KR, Turner RT, Spelsberg TC 1996 Estrogens and progestins. In: BilezikianJP (ed.) Principles of Bone Biology. Academic Press, San Diego, CA, U.S.A., pp. 507520
  • 3
    Lindsay R, Hart DM, Aitken JM, MacDonald EB, Anderson JB, Clarke AC 1976 Long-term prevention of postmenopausal osteoporosis by estrogen. Lancet 1: 10381041.
  • 4
    Stevenson JC, Cust MP, Gangar KF, Hillard TC, Lees B, Whitehead MI 1990 Effects of transdermal versus oral hormone replacement therapy on bone density in spine and proximal femur in postmenopausal women. Lancet 336: 265269.
  • 5
    Lindsay R, Tohme JF 1990 Estrogen treatment of patients with established postmenopausal osteoporosis. Obstet Gynecol 76: 290295.
  • 6
    Riis BJ 1995 The role of bone loss. Am J Med 95(Suppl 2A): 295325.
  • 7
    Fishman J, Schneider J, Hershcope RJ, Bradlow HL 1984 Increased estrogen 16α-hydroxylase activity in women with breast cancer and endometrial cancer. J Steroid Biochem 20: 10771081.
  • 8
    Schneider J, Kinne D, Fracchia A, Pierce V, Anderson KE, Bradlow HL, Fishman J 1982 Abnormal oxidative metabolism of estradiol in women with breast cancer. Proc Natl Acad Sci U S A 79: 30473051.
  • 9
    Martucci CP, Fishman J 1993 P450 enzymes of estrogen metabolism. Pharmacol Ther 57: 237257.
  • 10
    Swaneck GE, Fishman J 1984 Covalent binding of the endogenous estrogen 16α-hydroxyestrone to estradiol receptor in human breast cancer cells: Characterization and intranuclear localization. Proc Natl Acad Sci U S A 85: 78317835.
  • 11
    Fishman J, Martucci CP 1980 Biological properties of 16α-hydroxyestrone: Implications in estrogen physiology and pathophysiology. J Clin Endocrinol Metab 51: 611615.
  • 12
    Bradlow HL, Hershcopf RJ, Martucci CP, Fishman J 1985 16α-hydroxylation in the mouse correlates with mammary tumor incidence and presence of murine mammary tumor virus: A possible model for the hormonal etiology of breast cancer in humans. Proc Natl Acad Sci U S A 82: 62956299.
  • 13
    Schneider J, Huh MM, Bradlow HL, Fishman J 1984 Antiestrogen action of 2-hydroxyestrogen on MCF-7 human breast cancer cells. J Biol Chem 259: 48404845.
  • 14
    Martucci CP, Fishman J 1979 Impact of continuously administered catechol estrogens on uterine growth and lutenizing hormone secretion. Endocrinology 105: 12881292.
  • 15
    Vandewalle B, Lefebvre J 1989 Opposite effects of estrogen and catecholestrogen on hormone-sensitive breast cancer cell growth and differentiation. Mol Cell Endocrinol 61: 239246.
  • 16
    Osborne MP, Bradlow HL, Wong GYC, Telang NT 1993 Upregulation of estradiol C16α-hydroxylation in human breast tissue: A potential biomarger of breast cancer risk. J Natl Cancer Inst 85: 19171920.
  • 17
    Sepkovic DW, Bradlow HL, Ho G, Hankinson SE, Gong L, Osborne MP, Fishman J 1995 Estrogen metabolite ratios and risk assessment of hormone-related cancers. Assay validation and prediction of cervical cancer risk. Ann NY Acad Sci 768: 312316.
  • 18
    Lim SK, Won YJ, Lee JH, Kwon SH, Lec JL, Kim KR, Lee HC, Huh KB, Chung BC 1997 Altered hydroxylation of estrogen in patients with postmenopausal osteopenia. J Clin Endocrinol Metab 82: 10011006.
  • 19
    Cauley JA, Gutai JP, Kuller LH, Scott J, Nevitt MC 1994 Black-white differences in serum sex hormones and bone mineral density. Am J Epidemiol 139: 10351046.
  • 20
    Coker AL, Cranc MM, Sticca RP, Sepkovic DW 1997 Ethnic differences in estrogen metabolism in healthy women. J Natl Cancer Inst 89: 8990.
  • 21
    Westerlind KC, Gibson KS, Malone P, Evans GL, Turner RT 1998 Differential effects of estrogen metabolites on bone and reproductive tissues of ovariectomized rats. J Bone Miner Res 13: 10231031.
  • 22
    Subramaniam M, Harris SA, Oursler MJ, Rasmussen K, Riggs BL, Spelsberg TC 1995 Identification of a novel TGF-b regulated gene encoding a putative zinc finger protein in human osteoblasts. Nucleic Acids Res 23: 49074912.
  • 23
    Tau KR, Hefferan TE, Waters KM, Robinson JA, Subramaniam M, Riggs BL, Spelsberg TC 1998 Estrogen regulation of a TGF-β inducible early gene which inhibits DNA synthesis in human osteoblasts. Endocrinology 139: 13461353.
  • 24
    Subramaniam M, Hefferan TE, Tau KR, Peus D, Pittelkow M, Jalal S, Riggs BL, Roche P, Spelsberg TC 1998 Tissue, cell type, and breast cancer stage specific expression of a TGF-β inducible early transcription factor gene. J Cell Biochem 68: 226236.
  • 25
    Robinson JA, Harris SA, Riggs BL, Spelsberg TC 1997 Estrogen regulation of human osteoblastic cell proliferation and differentiation. Endocrinology 138: 29192927.
  • 26
    Harris SA, Enger RJ, Riggs BL, Spelsberg TC 1995 Development and characterization of a conditionally immortalized human fetal osteoblastic cell line. J Bone Miner Res 10: 178186.
  • 27
    Harris SA, Tau KR, Enger RJ, Toft DO, Riggs BL, Spelsberg TC 1995 Estrogen response in the hFOB1. 19 human fetal osteoblastic cell line stably transfected with the human estrogen receptor gene. J Cell Biochem 59: 193201.
  • 28
    McMaster GK, Carmichael GG 1977 Analysis of single- and double-stranded nucleic acids on polyacrylamide and agarose gels by glyoxal and acrinine orange. Proc Natl Acad Sci U S A 74: 48354838.
  • 29
    Adlercreutz H, Fotsis T, Hockerstedt K, Hamalainen E, Bannwart C, Bloigu S, Valtonen A, Ollus A 1989 Diet and urinary estrogen profile in premenopausal omnivorous and vegetarian women and in premenopausal women with breast cancer. J Steroid Biochem 34: 527530.
  • 30
    Kangas L 1992 Agonistic and antagonistic effects of antiestrogens in different target organs. Acta Oncol 31: 143146 (review).
  • 31
    Robinson JA, Spelsberg TC 1997 Mode of action at the cellular level with specific reference to bone cells. In: LindsayR, DempsterDW, JordanVC (eds.) Estrogens and Anti-Estrogens. Lippincott-Raven Publishers, Philadelphia, PA, U.S.A., pp. 4362
  • 32
    Jordan VC 1995 Alternate antiestrogens and approaches to the prevention of breast cancer. J Cell Biochem 22: 5157.
  • 33
    Grese TA, Dodge JA 1998 Selective estrogen receptor modulators (SERMS). Curr Pharmaceutical Design 4: 7192.
  • 34
    Bradlow HL, Telang NT, Sepkovic DW, Osborne MP 1996 2-hydroxyestrone: The good estrogen. J Endocrinol 150: S259S265.
  • 35
    Bodine PVN, Henderson RA, Green J, Aronow M, Owen T, Stein GS, Lian JB, Komm BS 1998 Estrogen receptor-α is developmentally regulated during osteoblast differentiation and contributes to selective responsiveness of gene expression. Endocrinology 139: 20482057.
  • 36
    Owen TA, Aronow MS, Barone LM, Bettencourt B, Stein GS, Lian JB 1991 Pleiotropic effects of vitamin D on osteoblast gene expression are related to the proliferative and differentiated state of the bone cell phenotype: Dependency upon basal levels of gene expression, duration of exposure, and bone matrix competency in normal rat osteoblast cultures. Endocrinology 128: 14961504.
  • 37
    Shalhoub V, Aslam F, Breen E, van Wijnen A, Bortell R, Stein GS, Lian JB 1998 Multiple levels of steroid hormone-dependent control of osteocalcin during osteoblast differentiation: Glucocorticoid regulation of basal and vitamin D stimulated gene expression. J Cell Biochem 69: 154168.
  • 38
    Kuiper GGJM, Carlsson B, Grandien K, Enmark E, Haggblad J, Nilsson S, Gustafsson J-A 1997 Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors α and β. Endocrinology 138: 863870.
  • 39
    McDonnell DP, Norris JD 1997 Analysis of the molecular pharmacology of estrogen receptor agonists and antagonists provides insights into the mechanism of action of estrogen in bone. Osteoporos Int Suppl 1: S29S34.
  • 40
    Barrett TJ, Spelsberg TC 1998 Steroid receptors at the nexus of transcriptional regulation. J Cell Biochem Suppl 30/31: 185193.
  • 41
    Yang NN, Venugopalan M, Hardikar S, Glasebrook A 1996 Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene. Science 273: 12221225.